Data analysis and delivery are the foundation of many consulting firms, and the healthcare industry is no exception. At present, the more mature medical consulting companies in the industry, such as Pharmaceutical Intelligence Consulting, Pharmaceutical Finance Research Institute, Yaodu Consulting, Minai and Rubik's Cube Consulting, all started from self-built pharmaceutical big data products, and then expanded and upgraded to data analysis + industry consulting to provide more high value-added service products.
PharmaIntelligence's company profile
Yaozhi Consulting is a problem solving and intellectual support service business in the pharmaceutical industry derived from the pharmaceutical big data platform of Yaozhi.com. Yaozhi can be traced back to 2006, Chongqing Kangzhou Science and Trade Co., Ltd. was established, and subsequently renamed Chongqing Kangzhou Big Data, mainly providing Internet information services in the field of medicine and health. In 2009, its first data service product, "Yaozhi.com", was launched. In March 2017, Yaozhi.com set up a consulting department team to provide medical data consulting services based on pharmaceutical information and data of Yaozhi.com, integrating internal and external expert resources.
Pharmaceutical Intelligence Consulting, IncData dimension parsing.
The PharmWisdom Network, on which PharmWisdom Consulting is based, is the core data for its strategic consulting services**. Based on the data of Yaozhi, Yaozhi has formed a big data platform for the pharmaceutical industry integrating medical equipment, media, and patents, among which Yaozhi data is its fist data product.
Pharmaceutical Intelligence Data integrates the medical intelligence information of major economies in Asia, Europe and the United States, and provides data on the pharmaceutical industry chain at home and abroad. At present, there are more than 200 underlying databases, clustered into 10 data clusters, namely drug research and development, consistency evaluation, production inspection, global listing, market information, rational drug use, medicinal chemistry, traditional Chinese medicine, medical devices, food and cosmetics.
Through its self-built big data products in the pharmaceutical industry, Yaozhi Consulting has obtained the ability to solve the consulting in the pharmaceutical industry and formed its own competitive advantage in the industry.
Pharmaceutical Intelligence Consulting, IncTalent team.
The talent team of the pharmaceutical consulting industry is one of the important factors affecting the quality of consulting services, which requires them to have many professional qualities such as pharmaceutical industry knowledge, statistical analysis ability, and forward-looking development strategic thinking. The Yaozhi consulting team was first composed of high-end talents such as the founder team of Yaozhi + special consultants. In 2019, there were 8 members of the Yaozhi consulting team (Yaozhi *** report), and the current number of the team is unknown, but according to its official website, the team's master's and doctoral coverage rate reached 80%, and there were 24 senior experts, most of whom were specially appointed cooperation models.
Pharmaceutical Intelligence Consulting, IncScope of business.
The consulting business can be divided into four major sectors, one is industrial research, such as industrial planning, industry research, policy research, and park planning, the second is project management, that is, drug project establishment, value evaluation, technical due diligence, patent analysis, etc., and the third is market research, including market insight, listing planning, product planning, and finally data customization. Generally speaking, the pharmaceutical consulting business is basically a solution to industry problems formed by pharmaceutical data as the underlying architecture.
Pharmaceutical Intelligence Consulting, IncPartners.
At present, there are three main types of pharmaceutical intelligence consulting partners:
The first is pharmaceutical enterprises, including domestic and foreign-funded pharmaceutical companies
The second is pharmaceutical investment institutions, including Xingye**, Tianhong**, etc.;
The third is the first institution, including Tianjin Pharmaceutical Research Institute, Suzhou Industrial Park Management Committee, etc.
Pharmaceutical Intelligence Consulting, IncFees.
Customized reporting services, the cost is based on the specific needs and the difficulty of the project**. Ready-made industry reports, such as diabetes ** drug market analysis 98,000 yuan, antiviral respiratory infection drug industry research report 5,000 yuan (for reference only).
Pharmaceutical Intelligence Consulting, IncOverall rating.
To sum up, with the big data platform of Yaozhi Network as the core and the support of consulting talents, Yaozhi Consulting has formed a data-driven strategic consulting service with its own unique development advantages. As an earlier medical data consulting service organization in the industry, it has achieved a good market share with a first-mover trend. It is worth noting that the emerging star Pharmaceutical Finance Research Institute in the same track is behind and forms a competitive situation with it.
Although the Pharmaceutical Finance Research Institute has not been established for a long time, the history of its team is the same period as Yaozhi.com. It originated from the scientific and technological information analysis team of the Chinese Academy of Sciences, relying on more than 15 years of professional data and intelligence analysis experience in biomedicine, and established an intelligence consulting service team with BCPM as the data source and the pharmaceutical finance circle as the intelligence pool.
BCPM is the four major database matrices of biology, chemistry, pharmacy and medicine, with billions of data. Among them, the flagship product, Yaorongyun Pharmaceutical Database, is basically at the top of the pharmaceutical data track in terms of data length and total data. Its first-class brand pharmaceutical finance circle has become an important platform for the link of high-end pharmaceutical talents, providing diversified intellectual support for the consulting business. According to its official website, it has reached in-depth cooperation with more than 500 leading companies in the pharmaceutical field.
Summary
With the awakening of the awareness of data-driven decision-making of pharmaceutical companies and the advancement of digitalization in the pharmaceutical industry, the domestic medical big data consulting industry is developing rapidly, and more and more outstanding enterprises are emerging, forming their own unique core advantages.